Asthma?
New study treatments that may put you back in control.

The respiratory condition that can make breathing difficult has several options on the market. But for those who still struggle with attacks, we’re working on giving you new options. Learn about the cutting-edge study treatments being investigated near you.
2%
of Americans
have been diagnosed with severe Asthma. 1
1.5
million people
use an inhaler everyday
100s
of treatments on the market
None of them a pill that stop attacks
I wish there was something else like a pill that you take once a week or per month to help with airwaves and breathing so I didn’t have to take the inhaler everywhere. That would be nice.
Patient
7 years with Asthma
I take my inhaler with me everywhere, I’m a control freak. My backpack always has water, cliff bar, allergy meds, and of course my inhaler is always in there too.
Patient
21 years with Asthma
Asthma Clinical Trials
Learn about the newest Asthma study treatments now being investigated, including cutting-edge options available to clinical trial participants.
TrialSpark is now recruiting for a trial that tests the effectiveness of a study drug for Asthma symptoms.
Asthma In the News
From the latest relevant research and Asthma expert interviews to personal stories and advice on managing your symptoms, here’s everything about Asthma that’s making headlines.
Switching and Combining Biologics for the Treatment of Severe Asthma
Without any head-to-head data or algorithms on the optimum method of choosing between the newly introduced biologics for the treatment of severe asthma, clinicians must observe patient clinical response after adequate trial periods, and then make changes as necessary, according to research presented at the American Thoracic Society’s International Conference, held May 17 to 22, in Dallas, Texas.
European Commission OKs Dupilumab (Dupixent) for Severe Asthma
The European Commission (EC) has approved dupilumab (Dupixent, Sanofi/Regeneron) as add-on maintenance therapy for patients aged 12 years or older with severe asthma with type 2 inflammation characterized by increased blood eosinophil levels and/or increased fractional exhaled nitric oxide, whose condition is poorly controlled with high-dose inhaled corticosteroid plus another medicine.
Long-term use of benralizumab appears safe, effective for severe asthma
Patients with severe eosinophilic asthma, who participated in three different Phase 3 trials of benralizumab (brand name Fasenra) and then enrolled in a long-term trial of the drug's efficacy and safety, continued to experience fewer exacerbations and improved pulmonary function and quality of life, according to research presented at ATS 2019.
Severe Asthma: Harnessing Biomarkers to Power Treatment Effectiveness
Dr Nicola Davies explores how phenotypes, endotypes, and biomarkers can be used to predict and assess treatment effectiveness for severe asthma.
New Study Sheds Light on the Challenges and Barriers of Severe Asthma Management
Though the majority of asthmatic patients experience mild to moderate symptoms, those with severe asthma face increased challenges when it comes to asthma management. A new but small study from The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice) highlights the support gaps that still need to be filled for patients living with severe asthma.
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
AstraZeneca’s Fasenra has been stealing share from GlaxoSmithKline’s Nucala in severe asthma, and competition is even fiercer with Sanofi’s Dupixent approval. Now, AZ has released an analysis of several trials showing Fasenra's positive effects for patients last up to two years.
FAQ
Whether you’re considering participating in a clinical trial or just looking for more information about Asthma, we want you to keep you informed about living with Asthma, your treatment options, and the clinical trial process.
Join an Asthma Community
Connect with others who have asthma to discuss your symptoms, experiences, treatment options, and more.
Stay updated on Asthma
We'll keep you updated on new and emerging treatments.
See if you qualify for a trial
New study treatments are being developed and investigated that may help address your condition.
Updated June 2019